While this column typically uses data visualizations you’ve probably seen before, I want to introduce one that perhaps you have not. This is in the realm of text analysis. When looking at FDA data, there are numerous places where the most interesting information is not in a data field that can be easily quantified, but
Following a two-day meeting by a Food and Drug Administration (“FDA”) advisory committee on breast implant safety earlier this year, FDA on May 2, 2019, released a statement announcing that no breast implant models will be banned from the U.S. market at this time. Also described in the statement are a number of measures the